Computational drug repositioning for rare diseases in the era of precision medicine
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference124 articles.
1. Rare-disease genetics in the era of next-generation sequencing: discovery to translation;Boycott;Nat. Rev. Genet.,2013
2. The missing voice of patients in drug-safety reporting;Basch;N. Engl. J. Med.,2010
3. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies 1;Lesko;Ann. Rev. Pharmacol. Toxicol.,2001
4. 2012 FDA drug approvals;Mullard;Nat. Rev. Drug Discov.,2013
5. Assessing the impact of HL7/FDA structured product label (SPL) content for medication knowledge management;Schadow,2007
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An Overview of Computational‐Based Strategies for Drug Repositioning;Integrating Metaheuristics in Computer Vision for Real‐World Optimization Problems;2024-07-31
2. Rare diseases and pyruvate kinase M2: a promising therapeutic connection;Drug Discovery Today;2024-05
3. Drug Repositioning for Amyloid Transthyretin Amyloidosis by Interactome Network Corrected by Graph Neural Networks and Transcriptome Analysis;Human Gene Therapy;2024-01-01
4. Methodologies Adopted in Drug Repurposing;Drug Repurposing;2024
5. The multiomics revolution in the era of deep learning: Allies or enemies?;Artificial Intelligence for Medicine;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3